Lepu Medical Technology (Beijing) Co., Ltd. (SZSE:300003) (the "Company") proposed spin-off its controlling Lepu subsidiary Changzhou Bingkun Medical Technology Co., Ltd. (hereinafter referred to as "Bingkun Medical") to GEM of Shenzhen Stock Exchange (hereinafter referred to as the " Proposed Spin-off"). After the completion of this proposed spin-off, the company's ownership structure will not change, and will still maintain control of Bingkun Medical. On July 21, 2023, the company held the second meeting of the sixth board of directors and the second meeting of the sixth board of supervisors.

Having considered and adopted the "Plan of Spin-off Changzhou Bingkun Medical Technology Co., Ltd. to the GEM listing of the Shenzhen Stock Exchange" and other motions related to this proposed spin-off. The proposed spin-off is subject to a number of conditions, including but not limited to obtaining the approval of the Company's shareholders' meeting; the formal approval of the proposed spin-off plan; the implementation of the relevant procedures of the Shenzhen Stock Exchange and the China Securities Regulatory Commission; and other procedures required by relevant laws and regulations.